Rishi Kant Singh
Overview
Explore the profile of Rishi Kant Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramani M, Singh R, Shrivastva S, Ribeyron L, Gupta S, Roy A
J Biol Chem
. 2024 Jul;
300(8):107578.
PMID: 39029626
Lenalidomide, a thalidomide derivative, is prescribed as maintenance therapy for multiple myeloma (MM). Patients with MM receiving lenalidomide were found to develop a distinct therapy-related B cell acute lymphoblastic leukemia...
2.
Kumar S, Mohan V, Singh R, Kumar Gautam P, Kumar S, Shukla A, et al.
Int Immunopharmacol
. 2024 Jun;
138:112584.
PMID: 38944948
Heat shock proteins are a widely distributed group of proteins. It is constitutively expressed in almost all organisms and shows little variation throughout evolution. Previously, HSPs, particularly Hsp70, were recognized...
3.
Kumar S, Shukla A, Singh S, Singh R, Patel A, Verma P, et al.
Cell Biochem Biophys
. 2024 May;
82(2):1043-1059.
PMID: 38696103
The therapeutic potential of chemically synthesized AuNPs has been demonstrated in various types of cancer. However, gold nanoparticles (AuNPs) synthesized using typical chemical methods have concerns regarding their environmental safety...
4.
Kumar N, Delu V, Ulasov I, Kumar S, Singh R, Kumar S, et al.
Cell Biochem Biophys
. 2024 Mar;
82(2):873-883.
PMID: 38483755
Nucleoside analogs are a common form of chemotherapy that disrupts DNA replication and repair, leading to cell cycle arrest and apoptosis. Reactive oxygen species (ROS) production is a significant mechanism...
5.
Kumar N, Shukla A, Kumar S, Ulasov I, Singh R, Kumar S, et al.
Cell Biochem Biophys
. 2024 Jan;
82(2):623-639.
PMID: 38253918
Cytotoxic nucleoside analogs (NAs) hold great promise in cancer therapeutics by mimicking endogenous nucleosides and interfering with crucial cellular processes. Here, we investigate the potential of the novel cytidine analog,...
6.
Kumar N, Kumar S, Shukla A, Kumar S, Singh R, Ulasov I, et al.
Discov Oncol
. 2024 Jan;
15(1):16.
PMID: 38252337
Purpose: T-cell lymphomas, refer to a diverse set of lymphomas that originate from T-cells, a type of white blood cell, with limited treatment options. This investigation aimed to assess the...
7.
Singh R, Kumar S, Kumar S, Shukla A, Kumar N, Patel A, et al.
Life Sci
. 2023 Aug;
330:121999.
PMID: 37536614
PKCα is a molecule with many functions that play an important role in cell survival and death to maintain cellular homeostasis. Alteration in the normal functioning of PKCα is responsible...
8.
Kumar N, Delu V, Shukla A, Singh R, Ulasov I, Fayzullina D, et al.
Asian Pac J Cancer Prev
. 2023 Jun;
24(6):2157-2170.
PMID: 37378948
Objectives: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2'-deoxy-2'-β-fluoro-4'-azidocytidine). FNC showed potent anti-viral and anti-cancer activities...
9.
Tomar M, Singh R, Ulasov I, Kaushalendra , Acharya A
Cancer Immunol Immunother
. 2022 Dec;
72(6):1429-1444.
PMID: 36460868
Natural killer (NK) cells play a crucial role in the anti-tumor transaction through cytolytic activity with the help of proportionate expression of their activating receptors (ARs) and inhibitory receptors (IRs)....
10.
Kumar S, Verma P, Shukla A, Singh R, Patel A, Yadav L, et al.
J Ethnopharmacol
. 2022 Oct;
302(Pt A):115849.
PMID: 36306933
Ethnopharmacological Relevance: The present work is based on a wide spectrum of evidences available from scientific literature which reflects nutritional and medicinal values of natural products such as plants and...